These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29593410)

  • 61. Indocyanine Green-Loaded Liposomes for Light-Triggered Drug Release.
    Lajunen T; Kontturi LS; Viitala L; Manna M; Cramariuc O; Róg T; Bunker A; Laaksonen T; Viitala T; Murtomäki L; Urtti A
    Mol Pharm; 2016 Jun; 13(6):2095-107. PubMed ID: 27097108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro.
    Behroozeh A; Mazloumi Tabrizi M; Kazemi SM; Choupani E; Kabiri N; Ilbeigi D; Heidari Nasab A; Akbarzadeh Khiyavi A; Seif Kurdi A
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):645-648. PubMed ID: 29580033
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes.
    Zhao T; Liu Y; Gao Z; Gao D; Li N; Bian Y; Dai K; Liu Z
    Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():196-203. PubMed ID: 26042707
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.
    Li M; Li Z; Yang Y; Wang Z; Yang Z; Li B; Xie X; Song J; Zhang H; Li Y; Gao G; Yang J; Mei X; Gong W
    Pharm Res; 2016 Aug; 33(8):1881-98. PubMed ID: 27075873
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vincristine sulfate liposome injection: a guide to its use in refractory or relapsed acute lymphoblastic leukemia.
    Harrison TS; Lyseng-Williamson KA
    BioDrugs; 2013 Feb; 27(1):69-74. PubMed ID: 23329395
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
    Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
    Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X
    J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro evaluation and finite element simulation of drug release from polydiacetylene-polyethylene glycol stearate nanovesicles.
    Guo C; Zeng L; Liu S; Chen Q; Dai Z; Wu X
    J Nanosci Nanotechnol; 2012 Jan; 12(1):245-51. PubMed ID: 22523972
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect.
    Lin J; Cai Q; Tang Y; Xu Y; Wang Q; Li T; Xu H; Wang S; Fan K; Liu Z; Jin Y; Lin D
    Int J Pharm; 2018 Jan; 536(1):272-282. PubMed ID: 29079221
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
    Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
    Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery.
    Wei K; Peng X; Zou F
    Int J Pharm; 2014 Apr; 464(1-2):225-33. PubMed ID: 24463073
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
    Ling G; Zhang P; Zhang W; Sun J; Meng X; Qin Y; Deng Y; He Z
    J Control Release; 2010 Dec; 148(2):241-8. PubMed ID: 20727928
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The construction and characterization of hybrid paclitaxel-in-micelle-in-liposome systems for enhanced oral drug delivery.
    Li Y; Chen Z; Cui Y; Zhai G; Li L
    Colloids Surf B Biointerfaces; 2017 Dec; 160():572-580. PubMed ID: 29028605
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aptamer-based liposomes improve specific drug loading and release.
    Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
    J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer.
    Liu X; Situ A; Kang Y; Villabroza KR; Liao Y; Chang CH; Donahue T; Nel AE; Meng H
    ACS Nano; 2016 Feb; 10(2):2702-15. PubMed ID: 26835979
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
    Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
    Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles.
    Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y
    Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.